INT171595

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.43
First Reported 2002
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 1.99
Pain Relevance 0.15

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

enzyme regulator activity (APOC3) transport (APOC3) extracellular space (APOC3)
small molecule metabolic process (APOC3) extracellular region (APOC3) lipid metabolic process (APOC3)
Anatomy Link Frequency
plasma 2
APOC3 (Homo sapiens)
Pain Link Frequency Relevance Heat
Bile 8 81.68 Quite High
agonist 13 48.28 Quite Low
Inflammation 5 5.00 Very Low Very Low Very Low
Inflammatory response 3 5.00 Very Low Very Low Very Low
Angina 2 5.00 Very Low Very Low Very Low
tolerance 2 5.00 Very Low Very Low Very Low
Spinal cord 1 5.00 Very Low Very Low Very Low
Pain 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Targeted Disruption 10 99.64 Very High Very High Very High
Disorder Of Lipid Metabolism 25 96.00 Very High Very High Very High
Hyperlipidemia 78 94.40 High High
Increased Venous Pressure Under Development 3 94.32 High High
Gallbladder Disease 1 76.96 Quite High
Syndrome 2 67.92 Quite High
Van Bogaert's Disease 3 59.28 Quite High
Coronary Artery Disease 14 5.00 Very Low Very Low Very Low
Stress 8 5.00 Very Low Very Low Very Low
INFLAMMATION 7 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The genetically determined deficiency of apoCIII in humans has been shown to increase the rate of TG clearance from plasma by 6- to 7-fold [36].
Negative_regulation (deficiency) of apoCIII in plasma
1) Confidence 0.43 Published 2002 Journal BMC Genet Section Body Doc Link PMC116591 Disease Relevance 0.62 Pain Relevance 0
A similar enhancement of TG clearance was observed in mice made apoCIII deficient by gene knockout experiments [6].
Negative_regulation (deficient) of apoCIII associated with targeted disruption
2) Confidence 0.37 Published 2002 Journal BMC Genet Section Body Doc Link PMC116591 Disease Relevance 0.54 Pain Relevance 0
increases APOA5 [54–56] and decreases APOC3 [57] transcription, resulting in a plasma TAG lowering effect, thereby, together with increased HDL concentrations, reducing the risk for atherosclerosis in humans [58].
Negative_regulation (decreases) of APOC3 in plasma associated with increased venous pressure under development and disorder of lipid metabolism
3) Confidence 0.30 Published 2010 Journal PPAR Research Section Body Doc Link PMC2933910 Disease Relevance 0.83 Pain Relevance 0.15

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox